Noteworthy Growth hormone dispute finds new venue

After being rejected by an administrative law judge of the International Trade Commission, Genentech Inc.'s effort to block Bio-Technology General Corp. and Novo-Nordisk A/S from importing human growth hormone into the U.S. has moved to federal court.

GNE has filed suit in the U.S. District Court for the District of Delaware alleging patent infringement, seeking damages from BTGC and Novo-Nordisk, and asking for an injunction blocking the two companies from